Učitavanje...
Re-Engineered p53 Chimera with Enhanced Homo-Oligomerization That Maintains Tumor Suppressor Activity
[Image: see text] The use of the tumor suppressor p53 for gene therapy of cancer is limited by the dominant negative inactivating effect of mutant endogenous p53 in cancer cells. We have shown previously that swapping the tetramerization domain (TD) of p53 with the coiled-coil (CC) from Bcr allows f...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Chemical Society
2014
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4114475/ https://ncbi.nlm.nih.gov/pubmed/24836513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp500202p |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|